Dec 7 (Reuters) - Champions Biotechnology Inc CSBR.O :
* CHAMPIONS ONCOLOGY REPORTS RECORD QUARTERLY REVENUE OF
$5.2
MILLION
* Q2 REVENUE ROSE 16.7 PERCENT TO $5.2 MILLION
* SEES FY 2018 REVENUE UP AT LEAST 20 PERCENT
* CHAMPIONS BIOTECHNOLOGY INC - REITERATED EXPECTATIONS FOR
FISCAL YEAR 2018 REVENUE GROWTH OF AT LEAST 20% OVER FISCAL YEAR
2017
* CHAMPIONS BIOTECHNOLOGY INC - QTRLY LOSS PER SHARE $0.01
* CHAMPIONS BIOTECHNOLOGY - REITERATES POSITION THAT "IT
DOES NOT
CURRENTLY INTEND TO RAISE CAPITAL IN THE EQUITY MARKET"
Source text for Eikon: ID:nPnb71SjQa
Further company coverage: CSBR.O
(Bangalore.newsroom@thomsonreuters.com)